Target intelligence / Profile preview

Myb-like, SWIRM and MPN domain-containing protein 1 (MYSM1)

Target
MYSM1
Molecular classification
Deubiquitinase enzyme, Metalloprotease, Chromatin-binding protein, Transcription coactivator, DNA-binding protein, Epigenetic regulator[1][2]
01

Overview

Myb-like, SWIRM and MPN domain-containing protein 1 (MYSM1) is a nuclear deubiquitinase and metalloprotease functioning as a chromatin modifier and epigenetic regulator, primarily by removing monoubiquitin from histone H2A, thereby modulating transcription. It plays key roles in hematopoietic stem cell differentiation, B-cell and NK-cell development, and in suppressing excessive innate immune and inflammatory responses by deubiquitinating substrate proteins in cytoplasmic signaling pathways. Dysfunction or mutation leads to bone marrow failure, immunodeficiency, and enhanced inflammation, marking it as both a regulator of gene expression and a therapeutic target in hematological and immune diseases[1][2].

Other names
MYSM1Myb-like SWIRM and MPN domains 1MYb-like SWIRM and MPN domain-containing protein 1Q5VVJ2[2][4]
02

Mechanism of action

Deubiquitination of monoubiquitinated histone H2A to relieve epigenetic repression. Attenuation of NOD2-mediated inflammation via K63-linked polyubiquitin removal. Inhibition of CGAS-STING pathway by cleavage of K63-linked ubiquitin chains on STING1. Regulation of gene expression involved in hematopoiesis and immune differentiation[2].

03

Biological functions

Chromatin remodelingDeubiquitination of histone H2APositive regulation of transcription by RNA polymerase IIRegulation of hematopoiesisImmune response modulationNegative regulation of innate immunity and inflammation[2]
04

Disease associations

Bone marrow failure syndromeImmunodeficiency (B-cell immunodeficiency)Skeletal dysplasia syndromeHematologic disordersInflammatory diseases (NOD2-mediated inflammation, autoimmune regulation)Diabetic retinopathy[2]
05

Safety considerations

Potential immune dysregulation if inhibited or lost (autoimmunity, immunodeficiency)Risk for bone marrow failure with abnormal function[2]
06

Biomarkers

Mutations in MYSM1 (potential for marrow failure and immunodeficiency syndromes)MYSM1 protein levels may indicate hematopoietic function[2]

Beyond the preview

Go deeper on Myb-like, SWIRM and MPN domain-containing protein 1 (MYSM1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myb-like, SWIRM and MPN domain-containing protein 1 (MYSM1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call